Table 1.
Sampling materials and methods of clinical application with PDAC samples.
Type of materials | Diagnostic detection | Method of detection | References |
---|---|---|---|
ctDNA/ctRNA | Amplification, deletion and translocation Gene driver mutations, Chromosomal abnormalities |
PCR Whole genome sequencing Next-generation sequencing |
Fabbri et al. (82) |
CTCs | Gene expression Cell Proliferation/growth Cell differentiation Cell mobility Apoptosis |
Next-generation sequencing Microarray testing qRT-PCR CTC Chip sequencing EPISOT Phenotypic analysis: immunostaining, FACS and LC-MS |
Pantel et al. (37) |
miRNA | Gene fusion transcripts RNA expression |
Next-generation sequencing Microarray testing qRT-PCR |
Tesfaye et al. (83) |
TEPs | Gene expression | Next-generation sequencing RNA sequencing |
Best et al. (84) Joosse et al. (40) |
PDAC, pancreatic ductal adenocarcinoma; LC-MS, liquid chromatography-mass spectrometry; FACS, fluorescence-activated single cell sorting; qRT-PCR, real time quantitative reverse transcription polymerase chain reaction.